Bhatt Nailesh 4
4 · Hyperliquid Strategies Inc · Filed Dec 12, 2025
Insider Transaction Report
Form 4
Bhatt Nailesh
Director
Transactions
- Other
Common Stock
2025-12-02+2,082→ 2,082 total
Footnotes (1)
- [F1]On December 2, 2025, Hyperliquid Strategies Inc (the "Company") completed its previously announced business combination (the "Closing"), pursuant to the Business Combination Agreement, dated as of July 11, 2025 (as amended on September 22, 2025, the "BCA"), by and among the Company, Sonnet BioTherapeutics Holdings, Inc. ("Sonnet"), Rorschach I LLC, TBS Merger Sub Inc. and Rorschach Merger Sub, LLC . In connection with the Closing, Ms. Nailesh Bhatt received 2,082 shares of common stock, par value $0.01 per share, of the Company, in exchange of certain securities of Sonnet Ms. Bhatt held prior to the Closing.